0000874015-21-000085.txt : 20210617 0000874015-21-000085.hdr.sgml : 20210617 20210617170501 ACCESSION NUMBER: 0000874015-21-000085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUTO FREDERICK T CENTRAL INDEX KEY: 0001181560 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 211025619 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-06-15 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001181560 MUTO FREDERICK T 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2021-06-15 2021-06-15 4 M 0 5000 9.3 A 36683 D Common Stock 2021-06-15 2021-06-15 4 S 0 5000 36.5 D 31683 D Common Stock 2021-06-15 2021-06-15 4 M 0 5000 9.3 A 36683 D Common Stock 2021-06-15 2021-06-15 4 S 0 5000 36.55 D 31683 D Common Stock 2021-06-15 2021-06-15 4 M 0 5000 9.3 A 36683 D Common Stock 2021-06-15 2021-06-15 4 S 0 5000 36.85 D 31683 D Non-Qualified Stock Option (right to buy) 9.3 2021-06-15 2021-06-15 4 M 0 5000 0.0 D 2012-07-01 2021-06-30 Common Stock 5000 10000 D Non-Qualified Stock Option (right to buy) 9.3 2021-06-15 2021-06-15 4 M 0 5000 0.0 D 2012-07-01 2021-06-30 Common Stock 5000 5000 D Non-Qualified Stock Option (right to buy) 9.3 2021-06-15 2021-06-15 4 M 0 5000 0.0 D 2012-07-01 2021-06-30 Common Stock 5000 0 D Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020. By: Patrick R. O'Neil, attorney-in-fact For: Frederick T. Muto 2021-06-16